The effect of daidzein on renal injury in ovariectomized rats: interaction of angiotensin receptors and long non-coding RNAs H19, GAS5, MIAT, and Rian

Background: Renin-angiotensin system (RAS) is prominently associated with renal pathophysiology in postmenopausal women. Long non-coding RNAs (lncRNAs) H19, GAS5, MIAT, and Rian have been linked to the pathogenesis of renal injury. Aims: This study aimed to evaluate the beneficial effects of daidzein on unilateral ureteral obstruction (UUO) induced-renal injury in ovariectomized (OVX) rats through interaction with angiotensin AT1, Mas receptors, and lncRNAs. Methods: 84 female rats were ovariectomized (OVX) two weeks before performing obstruction of the left kidney ureter (UUO). The animals were then randomly divided into four main groups (n=21): Sham+DMSO, UUO+DMSO, UUO+17β-Estradiol (E2) (positive control), and UUO+daidzein. Each main group comprised three subgroups (n=7) and were treated with saline, A779 (MasR antagonist), or losartan (AT1R antagonist) for 15 days. On day 16, the animals were euthanized, and the left kidneys were harvested for histopathology and lncRNAs expression assays. Results: UUO significantly increased kidney tissue damage score (KTDS) in the UUO rats, increased the expression of H19 and MIAT, and decreased the expression of GAS5 and Rian. Daidzein alone and in co-treatment with losartan or A779 reversed these effects. Daidzein with 1 mg/kg dose was more effective than E2. Conclusion: Daidzein alone and in co-treatment with A779 and losartan improved renal injury in UUO rats and recovered dysregulated expression of UUO-related lncRNAs through modulating MasR and AT1R receptors, associating with modulation of the expression of lncRNAs. Daidzein could be considered a renoprotective phytoestrogen substitute for E2 therapy in postmenopausal women suffering from renal diseases.

[1]  P. Proost,et al.  Isoflavone daidzein ameliorates renal dysfunction and fibrosis in a postmenopausal rat model: Intermediation of angiotensin AT1 and Mas receptors and microRNAs 33a and 27a , 2022, Iranian journal of basic medical sciences.

[2]  H. Najafipour,et al.  Perillyl alcohol and quercetin modulate the expression of non-coding RNAs MIAT, H19, miR-29a, and miR-33a in pulmonary artery hypertension in rats , 2022, Non-coding RNA research.

[3]  E. Jafari,et al.  Daidzein Mitigates Oxidative Stress and Inflammation in the Injured Kidney of Ovariectomized Rats: AT1 and Mas Receptor Functions. , 2022, Iranian journal of kidney diseases.

[4]  Laifang Li,et al.  Microarray analysis of differentially expressed long non-coding RNAs in daidzein-treated lung cancer cells , 2021, Oncology letters.

[5]  M. Kumar,et al.  Therapeutic Potential of Isoflavones with an Emphasis on Daidzein , 2021, Oxidative medicine and cellular longevity.

[6]  Dongyin Zhang,et al.  Exaggerated renal fibrosis in lncRNA Gas5-deficient mice after unilateral ureteric obstruction. , 2020, Life sciences.

[7]  Xiao-qin Zhang,et al.  Long noncoding RNA-GAS5 retards renal fibrosis through repressing miR-21 activity. , 2020, Experimental and molecular pathology.

[8]  S. Joukar,et al.  Perillyle alcohol and Quercetin ameliorate monocrotaline-induced pulmonary artery hypertension in rats through PARP1-mediated miR-204 down-regulation and its downstream pathway , 2020, BMC Complementary Medicine and Therapies.

[9]  Y. Kulkarni,et al.  Daidzein Attenuates Kidney Damage in Diabetic Rats , 2020, The FASEB Journal.

[10]  M. Rahmani,et al.  The effect of oleuropein on unilateral ureteral obstruction induced-kidney injury in rats: the role of oxidative stress, inflammation and apoptosis , 2019, Molecular Biology Reports.

[11]  T. Nag,et al.  The dietary isoflavone daidzein mitigates oxidative stress, apoptosis, and inflammation in CDDP‐induced kidney injury in rats: Impact of the MAPK signaling pathway , 2019, Journal of biochemical and molecular toxicology.

[12]  J. Qian,et al.  Effect of lncRNA-MIAT on kidney injury in sepsis rats via regulating miR-29a expression. , 2019, European review for medical and pharmacological sciences.

[13]  N. Wu,et al.  Down‐regulation of GAS5 ameliorates myocardial ischaemia/reperfusion injury via the miR‐335/ROCK1/AKT/GSK‐3β axis , 2019, Journal of cellular and molecular medicine.

[14]  R. Müller,et al.  Long Non-Coding RNAs in Kidney Disease , 2019, International journal of molecular sciences.

[15]  Z. Lv,et al.  A Novel lncRNA Regulates the Toll-Like Receptor Signaling Pathway and Related Immune Function by Stabilizing FOS mRNA as a Competitive Endogenous RNA , 2019, Front. Immunol..

[16]  T. Rabelink,et al.  Long Non-coding RNAs Rian and Miat Mediate Myofibroblast Formation in Kidney Fibrosis , 2019, Front. Pharmacol..

[17]  D. Mostafa,et al.  Phytoestrogens and Their Health Effect , 2019, Open access Macedonian journal of medical sciences.

[18]  S. Ying,et al.  LncRNA H19 promotes the proliferation of pulmonary artery smooth muscle cells through AT1R via sponging let-7b in monocrotaline-induced pulmonary arterial hypertension , 2018, RESPIRATORY RESEARCH.

[19]  M. Gao,et al.  [Role of signaling pathway of long non-coding RNA growth arrest-specific transcript 5/microRNA-200c-3p/angiotensin converting enzyme 2 in the apoptosis of human lung epithelial cell A549 in acute respiratory distress syndrome]. , 2018, Zhonghua yi xue za zhi.

[20]  Qiongjing Yuan,et al.  LncRNA ENST00000453774.1 contributes to oxidative stress defense dependent on autophagy mediation to reduce extracellular matrix and alleviate renal fibrosis , 2018, Journal of cellular physiology.

[21]  P. Blackshear,et al.  Hepatic tristetraprolin promotes insulin resistance through RNA destabilization of FGF21. , 2018, JCI insight.

[22]  Ming Wang,et al.  Novel inhibitors of the cellular renin‐angiotensin system components, poricoic acids, target Smad3 phosphorylation and Wnt/β‐catenin pathway against renal fibrosis , 2018, British journal of pharmacology.

[23]  S. Hou,et al.  Menopause in CKD. , 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  M. Bouvier,et al.  Ang-(1-7) is an endogenous β-arrestin-biased agonist of the AT1 receptor with protective action in cardiac hypertrophy , 2017, Scientific Reports.

[25]  Juan Shi,et al.  Transcriptome Identified lncRNAs Associated with Renal Fibrosis in UUO Rat Model , 2017, Front. Physiol..

[26]  M. James,et al.  The effect and safety of postmenopausal hormone therapy and selective estrogen receptor modulators on kidney outcomes in women: a protocol for systematic review and meta-analysis , 2017, Systematic Reviews.

[27]  Jianchang Chen,et al.  lncRNA MIAT functions as a competing endogenous RNA to upregulate DAPK2 by sponging miR-22-3p in diabetic cardiomyopathy , 2017, Cell Death & Disease.

[28]  X-H Zhu,et al.  LncRNA MIAT enhances cardiac hypertrophy partly through sponging miR-150. , 2016, European review for medical and pharmacological sciences.

[29]  Hong Xie,et al.  Long non-coding RNA-H19 antagonism protects against renal fibrosis , 2016, Oncotarget.

[30]  F. Dehghan,et al.  The brain cytokine levels are modulated by estrogen following traumatic brain injury: Which estrogen receptor serves as modulator? , 2015, International immunopharmacology.

[31]  Q. Ning,et al.  Losartan reverses the down-expression of long noncoding RNA-NR024118 and Cdkn1c induced by angiotensin II in adult rat cardiac fibroblasts. , 2015, Pathologie-biologie.

[32]  M. Nematbakhsh,et al.  Effect of Testosterone on Cisplatin-Induced Nephrotoxicity in Surgically Castrated Rats , 2014, Nephro-urology monthly.

[33]  M. Sánchez-Niño,et al.  Unilateral ureteral obstruction: beyond obstruction , 2014, International Urology and Nephrology.

[34]  Xueqing Yu,et al.  Identification of novel long noncoding RNAs associated with TGF-β/Smad3-mediated renal inflammation and fibrosis by RNA sequencing. , 2014, The American journal of pathology.

[35]  Nicholas T. Ingolia,et al.  Ribosome Profiling Provides Evidence that Large Noncoding RNAs Do Not Encode Proteins , 2013, Cell.

[36]  M. Gidekel,et al.  Daidzein-estrogen interaction in the rat uterus and its effect on human breast cancer cell growth. , 2012, Journal of medicinal food.

[37]  Xing Chen,et al.  LncRNADisease: a database for long-non-coding RNA-associated diseases , 2012, Nucleic Acids Res..

[38]  S. Salomone,et al.  Isoflavones: estrogenic activity, biological effect and bioavailability , 2012, European Journal of Drug Metabolism and Pharmacokinetics.

[39]  C. Ferrario.  ACE2: more of Ang-(1–7) or less Ang II? , 2011, Current opinion in nephrology and hypertension.

[40]  C. Maric,et al.  17beta-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-beta protein expression and signaling. , 2007, American journal of physiology. Renal physiology.

[41]  Yusuke Suzuki,et al.  Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. , 2004, Journal of the American Society of Nephrology : JASN.